The genesis of high-throughput structure-based drug discovery using protein crystallography
✍ Scribed by Peter Kuhn; Keith Wilson; Marianne G Patch; Raymond C Stevens
- Book ID
- 104414701
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 117 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1367-5931
No coin nor oath required. For personal study only.
✦ Synopsis
Over the past 12 years, drugs have been developed using structure-based drug design relying upon traditional crystallographic methods. Established successes, such as the drugs designed against HIV-1 protease and neuraminidase, demonstrate the utility of a structure-based approach in the drug-discovery process. However, the approach has historically lacked throughput and reliability capabilities; these bottlenecks are being overcome by breakthroughs in high-throughput structural biology. Recent technological innovations such as submicroliter high-throughput crystallization, high-performance synchrotron beamlines and rapid binding-site analysis of de novo targets using virtual ligand screening and small molecule co-crystallization have resulted in a significant advance in structure-based drug discovery.
📜 SIMILAR VOLUMES
Using a high degree of automation, the crystallography core at the Southeast Collaboratory for Structural Genomics (SECSG) has developed a high-throughput protein-to-structure pipeline. Various robots and automation procedures have been adopted and integrated into a pipeline that is capable of scree
The Structural Proteomics In Europe (SPINE) programme is aimed at the development and implementation of high-throughput technologies for the efficient structure determination of proteins of biomedical importance, such as those of bacterial and viral pathogens linked to human health. Despite the chal